摘要
多功能的治疗诊断试剂已经成为治疗肿瘤的冒险之举,因为其可以整合肿瘤的诊断和治疗。多功能的theranostic剂可以通过抗癌药物和各种癌症靶向配体的造影剂的化学偶联来探索获得。另一种方法是基于纳米探针,通过EPR效应或靶配体共轭,肿瘤靶向纳米结构可以实现同步的癌症特异性检测和治疗。有趣的是,最近有报道称发现了一个新兴的多功能小分子癌症靶向诊断治疗试剂。考虑到治疗诊断试剂的快速发展和对其发迫切需求,本文讨论了目前采用的和新出现的制备方法,并强调在每种方法的优点和挑战,以此来提供一个对发展更多的适合临床需求的癌症诊断剂的深刻见解。
关键词: 癌症治疗诊断,多功能剂,近红外成像,菁染料,纳米聚合物试剂。
Current Medicinal Chemistry
Title:Newly Emerging Theranostic Agents for Simultaneous Cancertargeted Imaging and Therapy
Volume: 23 Issue: 5
Author(s): Shenglin Luo, Xiaochao Yang, Chunmeng Shi
Affiliation:
关键词: 癌症治疗诊断,多功能剂,近红外成像,菁染料,纳米聚合物试剂。
摘要: The development of multifunctional theranostic agents has become an intriguing venture for personalized oncology, because they can integrate tumor diagnosis and therapy. One approach explored to obtain such multifunctional theranostic agents is through the chemical conjugation of anticancer drugs and contrast agents with various cancer-targeted ligands. The other approach is based on the nanoplatform, in which cancer-targeted nanostructures achieve simultaneous cancer specific detection and therapeutics either by EPR effect or by conjugation of target ligands. Interestingly, a newly emerging strategy from multifunctional small molecules to develop cancertargeted theranostic agents has been reported recently. In consideration of the urgent need and rapid development of theranostic agents in cancer therapy, herein we review the currently adopted and newly emerging approaches for their preparation, and highlight the promises and challenges in each approach, hoping to offer useful insights in developing more specific and efficient cancer theranostic agents suitable for clinical use.
Export Options
About this article
Cite this article as:
Shenglin Luo, Xiaochao Yang, Chunmeng Shi , Newly Emerging Theranostic Agents for Simultaneous Cancertargeted Imaging and Therapy, Current Medicinal Chemistry 2016; 23 (5) . https://dx.doi.org/10.2174/0929867323666151223095718
DOI https://dx.doi.org/10.2174/0929867323666151223095718 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Lemon Juice as a Biocatalyst Under Ultrasound Irradiation: Synthesis and Pharmacological Evaluation of 2-amino 1,3,4-thiadiazoles
Anti-Cancer Agents in Medicinal Chemistry Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
Current Pharmaceutical Design Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Current Drug Targets The Effects of β -Glucans on Dendritic Cells and Implications for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry In silico Based Structural Analysis of Some Piperidine Analogs as Farnesyltransferase Inhibitors
Medicinal Chemistry Preface [Hot topic: Anti-Cancer Drugs (Executive Editor : Elke Bergmann-Leitner)]
Current Pharmaceutical Design Retinoids in Clinical Use
Medicinal Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Microbial Biofilms: Impact on the Pathogenesis of Periodontitis, Cystic Fibrosis, Chronic Wounds and Medical Device-Related Infections
Current Topics in Medicinal Chemistry Interleukins Involved in Inflammatory Bowel Disease as New Therapeutic Targets
Current Immunology Reviews (Discontinued) Editorial [Hot topic: Emerging Therapeutic Targets and Agents for Glioblastoma Therapy – Part II (Guest Editor: Hui-Wen Lo)]
Anti-Cancer Agents in Medicinal Chemistry Ultrasonic Echolocation Device for Assisting the Visually Impaired
Current Medical Imaging MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment
MicroRNA LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers
Current Cancer Drug Targets Metabolic Syndrome and Cardiometabolic Risk Factors
Current Vascular Pharmacology Metallic Nanoclusters for Cancer Imaging and Therapy
Current Medicinal Chemistry Synthesis and Characterization of Folic Acid Conjugated Gemcitabine Tethered Silver Nanoparticles (FA-GEM-AgNPs) for Targeted Delivery
Current Pharmaceutical Design Protein Targeting Constructs in Alpha Therapy
Current Radiopharmaceuticals Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective
Current Rheumatology Reviews p73 as a Pharmaceutical Target for Cancer Therapy
Current Pharmaceutical Design